Moritz Mall
Moritz Mall is a junior group leader at the German Cancer Research Center (DKFZ) and founding member of the Hector Institute for Translational Brain Research (HITBR). His lab studies cellular plasticity—how cells change identity—a process central to cancer and neurodevelopmental disorders. Using stem cell and organoid models of brain and liver, his team investigates the genetic and epigenetic control of disease transitions to discover new treatments.
Moritz studied at LMU Munich and ETH Zürich, earned his PhD at EMBL Heidelberg, and trained at Stanford University as a German Research Foundation postdoctoral fellow. He has received several awards, including an ERC Starting Grant and the Hella Bühler Prize for cancer research.
In addition to his research, Moritz is committed to outreach and translational science. He actively supports families affected by rare autism-associated disorders and works closely with patient communities. His team’s research has already contributed to compassionate-use therapies, showing how patient-driven science can help bring targeted treatments to the clinic.
Check out more of his lab's work on their website or in this clip.
